AEON Biopharma, Inc. (AEON) Operating cash flow 2021–2025
AEON Biopharma, Inc. (AEON) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$17.3MFY2025 · since FY2021: -$1.5M → -$17.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.3M | +14.7% |
| FY2024 | -$20.3M | — |
| FY2022 | -$35.6M | -2280.5% |
| FY2021 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AEON financial trends
AEON RevenueAEON Net incomeAEON Net marginAEON Gross profitAEON Gross marginAEON Operating incomeAEON Operating marginAEON Free cash flowAEON Capital expendituresAEON Return on equityAEON Stock buybacksAEON Dividends paidAEON Total assetsAEON Total liabilitiesAEON Shareholders’ equityAEON overview →